Drug Discovery & Development Services

Transforming R&D with proven AI

Drug innovators know it takes 10-15 years and nearly $2 billion to bring a new drug to market. Without the right data and data science expertise, the process is inefficient and can lead to a lower probability of success.

IQVIA’s Drug Discovery & Development Services provide solutions aimed at dramatically improving these statistics while minimizing risk.

Leverage IQVIA’s AI/ML and domain expertise to improve accuracy and lower costs

Our focus is on expediting drug development by harnessing proven artificial intelligence (AI) and machine learning (ML) from design through the prediction of clinical trial success—decreasing time and cost, while optimizing clinical outcomes. Our expansive portfolio of capabilities and technologies, unparalleled data, and global healthcare expertise provide macro- and micro-level insights to deliver a competitive edge.

Bring drugs to market faster with greater accuracy

IQVIA’s machine learning platforms and AI models can do everything from helping generate new and stable molecular compounds to predicting technical and regulatory success. Drug Discovery & Development Services enable our partners to uncover new opportunities and adapt to challenges with speed, agility, and confidence.

IQVIA has the global scale and expertise to reveal unseen insights, drive smarter decisions and discover new opportunities faster.

Contact Us